Skip to main content

Part of the book series: New Vistas in Drug Research ((DRUG RESEARCH,volume 1))

  • 76 Accesses

Summary

In a previous study, the daily urinary excretion of total (R + S) salsolinol was shown to be significantly lower in de novo parkinsonian patients than in healthy volunteers.

Here, we report on the urinary concentrations and daily urinary excretion of (R)- and (S)-salsolinol in an additional sample of 12 healthy subjects and 9 de novo parkinsonians. The urinary concentrations of both enantiomers of salsolinol were lower than the limit of detection in the urine of the parkinsonians. (R)-Salsolinol was detectable in the urine of 8 healthy subjects, whereas (S)-salsolinol was detectable in the urine of 3 only. Since 1,2-dehydrosalsolinol was present in the urine of parkinsonian patients, it is suggested that salsolinol bioprecursors such as 1,2-dehydrosalsolinol and 1-carboxysalsolinol might be additional markers for the early detection of Parkinson’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Brossi A (1982) Mammalian TIQ’s: products of condensation with aldehydes or pyruvic acid? Prog Clin Biol Res 90: 123–133

    Google Scholar 

  • Dordain G, Dostert P, Strolin Benedetti M, Rovei V (1984) Tetrahydroisoquinoline derivatives and parkinsonism. In: Tipton KF, Dostert P, Strolin Benedetti M (eds) Monoamine oxidase and disease. Prospects for therapy with reversible inhibitors. Academic Press, London, pp 417–426

    Google Scholar 

  • Dostert P, Strolin Benedetti M, Dedieu M (1987) Ratio of enantiomers of salsolinol in human urine. Pharmacol Toxicol 60 [Suppl 1]: 13

    Google Scholar 

  • Dostert P, Strolin Benedetti M, Bellotti V, Allievi C, Dordain G (1990) Biosynthesis of salsolinol, a tetrahydroisoquinoline alkaloid, in healthy subjects. J Neural Transm 81: 215–223

    Article  CAS  Google Scholar 

  • Pianezzola E, Bellotti V, Fontana E, Moro E, Gal J, Desai DM (1989) Determination of the enantiomeric composition of salsolinol in biological samples by high-performance liquid chromatography with electrochemical detection. J Chromatogr Biomed Appl 495: 205–214

    Article  CAS  Google Scholar 

  • Robbins JH (1968) Possible alkaloid formation in alcoholism and other diseases. Clin Res 16: 554

    Google Scholar 

  • Sandler M, Bonham Carter S, Hunter KR, Stern GM (1973) Tetrahydroisoquinoline alkaloids: in vivo metabolites of L-dopa in man. Nature 241: 439–443

    Article  PubMed  CAS  Google Scholar 

  • Strolin Benedetti M, Bellotti V, Pianezzola E, Moro E, Carminati P, Dostert P (1989a) Ratio of the R and S enantiomers of salsolinol in food and human urine. J Neural Transm 77: 47–53

    Article  CAS  Google Scholar 

  • Strolin Benedetti M, Dostert P, Carminati P (1989b) Influence of food intake on the enantiomeric composition of urinary salsolinol in man. J Neural Transm [Gen Sect] 78: 43–51

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag/Wien

About this chapter

Cite this chapter

Dostert, P., Strolin Benedetti, M., Dordain, G. (1990). Salsolinol and the early detection of Parkinson’s disease. In: Dostert, P., Riederer, P., Strolin Benedetti, M., Roncucci, R. (eds) Early Markers in Parkinson’s and Alzheimer’s Diseases. New Vistas in Drug Research, vol 1. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9098-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9098-2_11

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-9100-2

  • Online ISBN: 978-3-7091-9098-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics